Physician profile
Christopher M Thomas
NPI 1386038164
$8,075.89
in general payments reported to CMS, 2019-2025
10 companies · $2,011 in 2025
The $2,011 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,183 · 2020: $45.08 · 2021: $112 · 2022: $2,456 · 2023: $249 · 2024: $19.55 · 2025: $2,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,309 · Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,308.70 |
| Food and Beverage | $970.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $3,183.00 | 2019 | |
| Summit Surgical Corp. | $2,410.57 | 2022 | |
| Smith+Nephew, INC. | $1,921.40 | 2021-2025 | Real Intelligence, Journey II, Journey |
| Zimmer Biomet Holdings, INC. | $300.70 | 2022-2025 | G7, Comprehensive |
| Si-Bone, INC. | $79.98 | 2023 | |
| Axogen | $59.92 | 2020-2023 | Avance Nerve Graft |
| Skeletal Dynamics INC | $49.50 | 2021 | |
| Invictus Surgical Incorporated | $28.56 | 2025 | |
| Endo Pharmaceuticals INC. | $26.80 | 2020 | |
| Depuy Synthes Sales INC. | $15.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.